Novoron Bioscience Teams with Expesicor to Develop Neuroregenerative Compounds for Epilepsy and Alzheimer’s Disease
KALISPELL, MT, July 24, 2018 -- Novoron Bioscience, a private biotechnology company developing novel therapeutic approaches to address disorders of the central nervous system, announced a strategic partnership today with Expesicor to develop Novoron’s novel compounds to treat epilepsy and neurodegenerative disorders. Expesicor has extensive experience in drug development for neurological disorders, ranging from preclinical to Phase II clinical trials.
“We are thrilled to work with Expesicor to further develop our compounds for the benefit of those with epilepsy, Alzheimer’s disease (AD), and other neurological disorders,” commented Travis Stiles, PhD, CEO of Novoron. “Expesicor’s unique expertise and experience in both AD and epilepsy is a huge value-add in expanding our pipeline beyond multiple sclerosis and spinal cord injury.”
“We’re excited to be working with Novoron’s world class researchers to develop their unique compounds to treat, and perhaps even cure, epilepsy and neurodegenerative disorders. In just a short time, this collaborative effort has already borne fruit, which tells us we’re on the right track.” said Expesicor CEO Braxton Norwood, PhD.
About Novoron Bioscience
Novoron Bioscience is a private biotech company developing novel therapeutic approaches to address disorders of the central nervous system. The company has made proprietary scientific discoveries in treatment of various pathologies of the central nervous system and is advancing a pipeline of biologic therapeutics for multiple sclerosis, spinal cord injury and glaucoma. Novoron is headquartered in San Diego and is part of the JLABS innovation community. For more information, visit novoron.com.
About Expesicor
Expesicor is a privately-held Montana-based company focused on preventing, treating, and curing neurological disorders. Expesicor’s development pipeline includes proprietary therapeutics, imaging probes, and drug screening tools for epilepsy, neurodegenerative disorders, depression, and other brain disorders. For more information, visit expesicor.com.
